Impact of COVID-19 on cancer service delivery: results from an international survey of oncology clinicians.
Fiche du document
- doi: 10.1136/esmoopen-2020-001090
- issn: 2059-7029
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/doi/10.1136/esmoopen-2020-001090
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pmid/33262203
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/eissn/2059-7029
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_EBC36A1764E13
info:eu-repo/semantics/openAccess , CC BY-NC 4.0 , https://creativecommons.org/licenses/by-nc/4.0/
Sujets proches
Cancer specialists Cancerologists Carcinoma Cancers Malignancy (Cancer) Malignant tumorsCiter ce document
G. Chazan et al., « Impact of COVID-19 on cancer service delivery: results from an international survey of oncology clinicians. », Serveur académique Lausannois, ID : 10.1136/esmoopen-2020-001090
Métriques
Partage / Export
Résumé
To report clinician-perceived changes to cancer service delivery in response to COVID-19. Multidisciplinary Australasian cancer clinician survey in collaboration with the European Society of Medical Oncology. Between May and June 2020 clinicians from 70 countries were surveyed; majority from Europe (n=196; 39%) with 1846 COVID-19 cases per million people, Australia (AUS)/New Zealand (NZ) (n=188; 38%) with 267/236 per million and Asia (n=75; 15%) with 121 per million at time of survey distribution. Medical oncologists (n=372; 74%), radiation oncologists (n=91; 18%) and surgical oncologists (n=38; 8%). Eighty-nine per cent of clinicians reported altering clinical practices; more commonly among those with versus without patients diagnosed with COVID-19 (n=142; 93% vs n=225; 86%, p=0.03) but regardless of community transmission levels (p=0.26). More European clinicians (n=111; 66.1%) had treated patients diagnosed with COVID-19 compared with Asia (n=20; 27.8%) and AUS/NZ (n=8; 4.8%), p